120 - What About Non-Beta-Lactam Allergies? Case Discussion Including Management Strategies

Friday, October 13, 2023

10:30 AM – 11:45 AM US ET

Location: 156 ABC

All relevant financial disclosures have been mitigated.

Interactive Moderator(s)

Christopher Bland, PharmD, FCCP, FIDSA, BCPS

Albert W. Jowdy Professor in Pharmacy Care
Pharmacy
University of Georgia College of Pharmacy
Savannah, GA, United States
Bruce Jones, Pharm.D., FIDSA, BCPS

Infectious Diseases Clinical Pharmacy Specialist
St. Joseph's/Candler Health System
Savannah, GA, United States

Slides

Panelist(s)

Kimberly Blumenthal, MD MSc

MD
Department of Medicine, Division of Rheumatology, Allergy, and Immunology
Massachusetts General Hospital
Boston, MA, United States
TC

Tatjana Calvano, DO (she/her/hers)

Infectious Disease Physician, Associate Professor, Program Director
Madigan Army Medical Center
Joint Base Lewis-McChord, WA, United States
Wesley Kufel, PharmD, BCPS, BCIDP, AAHIVP

Clinical Associate Professor
Binghamton University School of Pharmacy and Pharmaceutical Sciences
Binghamton, NY, United States

Disclosure(s):

Christopher M. Bland, PharmD, FCCP, FIDSA, BCPS: Nestle/Seres: Advisor/Consultant (Ongoing), Honoraria (Ongoing); Shionogi & Company, Limited: Advisor/Consultant (Ongoing), Honoraria (Ongoing)

Bruce M. Jones, Pharm.D., FIDSA, BCPS: AbbVie Inc: Advisor/Consultant (Ongoing), Honoraria (Ongoing); La Jolla: Honoraria (Ongoing); Paratek Pharmaceuticals: Honoraria (Ongoing)

Kimberly G. Blumenthal, MD MSc: ThermoFisher Scientific: Grant/Research Support (Ongoing)

Tatjana Calvano, DO: No financial relationships to disclose

Wesley D. Kufel, PharmD, BCPS, BCIDP, AAHIVP: Merck and Co: Grant/Research Support (Ongoing)

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
CNE Credits: Maximum of 1.25 hours of ANCC Credit
ACPE Credits: ACPE 1.25 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-0000-23-002-L01-P

Learning Objectives:

At the conclusion of this session, participants will be able to:

identify common non beta-lactam allergies including macrolide, fluoroquinolone, and sulfa through case studies;
analyze various options for management of non beta-lactam allergies;
determine most appropriate treatment strategies based on available outcome data and resources